ALPS Medical Breakthroughs ETF (SBIO)
NYSEARCA: SBIO · Real-Time Price · USD
28.77
+0.38 (1.33%)
At close: May 19, 2025, 4:00 PM
28.77
0.00 (0.00%)
After-hours: May 19, 2025, 8:00 PM EDT
SBIO Holdings List
As of May 16, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | VRNA | Verona Pharma plc | 5.28% |
2 | ALKS | Alkermes plc | 4.47% |
3 | AXSM | Axsome Therapeutics, Inc. | 4.26% |
4 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.41% |
5 | ACAD | ACADIA Pharmaceuticals Inc. | 3.26% |
6 | RNA | Avidity Biosciences, Inc. | 3.26% |
7 | PTCT | PTC Therapeutics, Inc. | 3.24% |
8 | ZLAB | Zai Lab Limited | 2.90% |
9 | AKRO | Akero Therapeutics, Inc. | 2.78% |
10 | MRUS | Merus N.V. | 2.61% |
11 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.58% |
12 | PTGX | Protagonist Therapeutics, Inc. | 2.52% |
13 | MLTX | MoonLake Immunotherapeutics | 2.18% |
14 | XENE | Xenon Pharmaceuticals Inc. | 2.06% |
15 | MIRM | Mirum Pharmaceuticals, Inc. | 1.96% |
16 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.92% |
17 | VCEL | Vericel Corporation | 1.89% |
18 | DNLI | Denali Therapeutics Inc. | 1.88% |
19 | NAMS | NewAmsterdam Pharma Company N.V. | 1.80% |
20 | CGON | CG Oncology, Inc. | 1.76% |
21 | FOLD | Amicus Therapeutics, Inc. | 1.76% |
22 | APGE | Apogee Therapeutics, Inc. | 1.66% |
23 | GLPG | Galapagos NV | 1.65% |
24 | AGIO | Agios Pharmaceuticals, Inc. | 1.52% |
25 | IRON | Disc Medicine, Inc. | 1.51% |
26 | TARS | Tarsus Pharmaceuticals, Inc. | 1.50% |
27 | LQDA | Liquidia Corporation | 1.45% |
28 | IDYA | IDEAYA Biosciences, Inc. | 1.34% |
29 | IMCR | Immunocore Holdings plc | 1.34% |
30 | GPCR | Structure Therapeutics Inc. | 1.34% |
31 | CLDX | Celldex Therapeutics, Inc. | 1.25% |
32 | EWTX | Edgewise Therapeutics, Inc. | 1.24% |
33 | VERA | Vera Therapeutics, Inc. | 1.21% |
34 | MNKD | MannKind Corporation | 1.18% |
35 | AUPH | Aurinia Pharmaceuticals Inc. | 0.99% |
36 | VRDN | Viridian Therapeutics, Inc. | 0.97% |
37 | NVAX | Novavax, Inc. | 0.94% |
38 | RCUS | Arcus Biosciences, Inc. | 0.81% |
39 | NTLA | Intellia Therapeutics, Inc. | 0.81% |
40 | PHVS | Pharvaris N.V. | 0.74% |
41 | NUVB | Nuvation Bio Inc. | 0.68% |
42 | PRAX | Praxis Precision Medicines, Inc. | 0.68% |
43 | MLYS | Mineralys Therapeutics, Inc. | 0.65% |
44 | IMNM | Immunome, Inc. | 0.62% |
45 | AVXL | Anavex Life Sciences Corp. | 0.61% |
46 | AVBP | ArriVent BioPharma, Inc. | 0.60% |
47 | VIR | Vir Biotechnology, Inc. | 0.58% |
48 | ANAB | AnaptysBio, Inc. | 0.57% |
49 | DNTH | Dianthus Therapeutics, Inc. | 0.57% |
50 | FLGT | Fulgent Genetics, Inc. | 0.57% |
51 | DAWN | Day One Biopharmaceuticals, Inc. | 0.56% |
52 | REPL | Replimune Group, Inc. | 0.54% |
53 | KROS | Keros Therapeutics, Inc. | 0.51% |
54 | XNCR | Xencor, Inc. | 0.51% |
55 | STOK | Stoke Therapeutics, Inc. | 0.48% |
56 | SVRA | Savara Inc. | 0.44% |
57 | UPB | Upstream Bio, Inc. | 0.41% |
58 | TBPH | Theravance Biopharma, Inc. | 0.41% |
59 | AMLX | Amylyx Pharmaceuticals, Inc. | 0.40% |
60 | CAPR | Capricor Therapeutics, Inc. | 0.38% |
61 | CELC | Celcuity Inc. | 0.37% |
62 | ZBIO | Zenas BioPharma, Inc. | 0.36% |
63 | MBX | MBX Biosciences, Inc. | 0.36% |
64 | TRML | Tourmaline Bio, Inc. | 0.35% |
65 | PRTA | Prothena Corporation plc | 0.33% |
66 | ERAS | Erasca, Inc. | 0.33% |
67 | AUTL | Autolus Therapeutics plc | 0.33% |
68 | CMPS | COMPASS Pathways plc | 0.32% |
69 | RAPP | Rapport Therapeutics, Inc. | 0.32% |
70 | RIGL | Rigel Pharmaceuticals, Inc. | 0.32% |
71 | URGN | UroGen Pharma Ltd. | 0.29% |
72 | OLMA | Olema Pharmaceuticals, Inc. | 0.29% |
73 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.28% |
74 | ITOS | iTeos Therapeutics, Inc. | 0.27% |
75 | AURA | Aura Biosciences, Inc. | 0.27% |
76 | RNAC | Cartesian Therapeutics, Inc. | 0.24% |
77 | VNDA | Vanda Pharmaceuticals Inc. | 0.21% |
78 | ATXS | Astria Therapeutics, Inc. | 0.21% |
79 | SLRN | Acelyrin, Inc. | 0.21% |
80 | ANNX | Annexon, Inc. | 0.20% |
81 | RZLT | Rezolute, Inc. | 0.19% |
82 | CRGX | CARGO Therapeutics, Inc. | 0.17% |
83 | YMAB | Y-mAbs Therapeutics, Inc. | 0.17% |
84 | ELDN | Eledon Pharmaceuticals, Inc. | 0.16% |
85 | FDMT | 4D Molecular Therapeutics, Inc. | 0.14% |
86 | ACRS | Aclaris Therapeutics, Inc. | 0.13% |
87 | ALDX | Aldeyra Therapeutics, Inc. | 0.12% |
88 | LRMR | Larimar Therapeutics, Inc. | 0.12% |
89 | ENTA | Enanta Pharmaceuticals, Inc. | 0.11% |
90 | ALEC | Alector, Inc. | 0.11% |
91 | NMRA | Neumora Therapeutics, Inc. | 0.10% |
92 | MGNX | MacroGenics, Inc. | 0.09% |
93 | PROK | ProKidney Corp. | 0.09% |
94 | KYTX | Kyverna Therapeutics, Inc. | 0.09% |
95 | ZNTL | Zentalis Pharmaceuticals, Inc. | 0.08% |
96 | IRWD | Ironwood Pharmaceuticals, Inc. | 0.08% |
97 | PLRX | Pliant Therapeutics, Inc. | 0.08% |
98 | STRO | Sutro Biopharma, Inc. | 0.07% |
99 | n/a | State Street Instl Trs Pls MMkt Premier | 0.05% |
100 | LON: AZN | AstraZeneca PLC | 0.00% |
101 | n/a | Azn Ln - Cvr | 0.00% |
102 | n/a | Omniab | 0.00% |
103 | n/a | Omniab | 0.00% |
104 | n/a | Radius Health Cvr | 0.00% |
105 | n/a | Chinook Therapeutics, Inc. | 0.00% |
106 | n/a | Cash | -0.01% |
As of May 16, 2025